In Alzheimer-prone brain regions, metabolism and risk-gene expression are strongly correlated is a research paper published in Brain Communications (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U01 AG024904
DOD ADNI
Grant: W81XWH-12-2-0012
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
Canadian Institutes of Health Research
Grant: unidentified
unidentified
Araclon Biotech
Elan Pharmaceuticals, Inc.
Lumosity
McGee Family Foundation
Meso Scale Diagnostics, LLC
National Institute on Aging
Alzheimer’s Association
Alzheimer’s Drug Discovery Foundation
Biogen
Cogstate
National Institutes of Health
NeuroRx Research
Transition Therapeutics
University of Southern California
ADNI
Bristol-Myers Squibb Company
CereSpir, Inc.
Eisai Inc.
Fujirebio
Eli Lilly and Company
Genentech, Inc.
Houston Methodist Foundation and by the Moody Foundation
Servier
Alzheimer’s Therapeutic Research Institute
BioClinica, Inc.
GE Healthcare
IXICO Ltd
Johnson & Johnson Pharmaceutical Research & Development
Merck & Co., Inc.
Neurotrack Technologies
The Moody Foundation
F. Hoffmann-La Roche Ltd
Laboratory for Neuro Imaging
Takeda Pharmaceutical Company
EuroImmun
National Institute of Biomedical Imaging and Bioengineering
Novartis Pharmaceuticals Corporation
Janssen Alzheimer Immunotherapy Research & Development
Lundbeck
Northern California Institute for Research and Education
Pfizer Inc
Piramal Imaging
Rice University Graduate and Postdoctoral Studies
Fields of Study
Keywords
Sustainable Development Goals